EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan

Hirokazu Kashiwagi, Isao Miura, Naohiko Terasawa, Ken-Ichi Iwayama, Yuka Furukawa, Makoto Kanenishi

International Journal of Hematology · 2025-03 · 121 (3) · 363-377

DOI: 10.1007/s12185-024-03897-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Hematology, online erschienen am 12.12.2024. Verfasst von Hirokazu Kashiwagi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Postal Address: 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. ka…. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Adrenal Cortex Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kissei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent trends in the treatment of primary immune thrombocytopenia (ITP) were investigated using a claims database that included data from 16,161 Japanese patients with ITP collected from April 2014 to August 2022. Of the 4144 adult patients analyzed, 1276 received corticosteroids. The mean and median durations of corticosteroid use were 115.31 and 41 days, respectively. The time to withdrawal of corticosteroids was significantly shorter in 2020 to 2021 than in 2015 to 2019. Additionally, the number of prescriptions for thrombopoietin receptor agonists increased from 2015 to 2021 and exceeded that of corticosteroids in 2021. While these results suggest a trend towards reduction in corticosteroid use in real-world settings in Japan, 12.00% of patients received a corticosteroid dose of ≥ 10 mg/day at Week 12. Furthermore, 23.05% of patients continued to receive corticosteroids at Week 24, indicating that some patients were still receiving long-term corticosteroid treatment. The risk of adverse outcomes was significantly associated with corticosteroid use. In conclusion, new treatment options may lead to more sophisticated ITP management with less corticosteroid use, although further research and reconsideration of clinical practice guidelines is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicAdrenal Cortex HormonesHumansJapanMaleAdultMiddle AgedFemaleDatabases, FactualAgedReceptors, ThrombopoietinAged, 80 and overYoung Adult

Stichwörter der Autor:innen

Adverse effectCorticosteroidsDatabase studyImmune thrombocytopeniaTreatment pattern

Substanzen

Adrenal Cortex HormonesReceptors, Thrombopoietin

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Postal Address: 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. kashi@hp-blood.med.osaka-u.ac.jp.
  • Osaka Red Cross Blood Center, Osaka, Japan. kashi@hp-blood.med.osaka-u.ac.jp.
  • Medical Department, Kissei Pharmaceutical Co., Ltd, Tokyo, Japan.
  • RWE Group Clinical Research Department, Ark Medical Solutions Inc, Tokyo, Japan.

Förderung

  • Kissei

Zitieren

APA

Kashiwagi, H., Miura, I., Terasawa, N., Iwayama, K. I., Furukawa, Y., & Kanenishi, M. (2025). Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan. International Journal of Hematology, 121(3), 363-377. https://doi.org/10.1007/s12185-024-03897-8

Vancouver

Kashiwagi H, Miura I, Terasawa N, Iwayama KI, Furukawa Y, Kanenishi M. Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan. International Journal of Hematology. 2025;121(3):363-377. doi:10.1007/s12185-024-03897-8

BibTeX
@article{Kashiwagi2025,
  author = {Kashiwagi, Hirokazu and Miura, Isao and Terasawa, Naohiko and Iwayama, Ken-Ichi and Furukawa, Yuka and Kanenishi, Makoto},
  title = {Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan},
  journal = {International Journal of Hematology},
  year = {2025},
  volume = {121},
  number = {3},
  pages = {363--377},
  doi = {10.1007/s12185-024-03897-8}
}
Kostenlos starten →